CVE:LTY Liberty Biopharma (LTY) Stock Price, News & Analysis → Exposed: 10 CENT Crypto to Explode April 20th? (From True Market Insiders) (Ad) Free LTY Stock Alerts C$2.00 +2.00 (+∞) (As of 10/10/2018) Add Compare Share Share Today's RangeC$2.00▼C$2.0050-Day RangeC$2.00▼C$2.0052-Week RangeC$0.06▼C$2.74Volume700 shsAverage Volume23,286 shsMarket CapitalizationC$21.54 millionP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock Analysis Get Liberty Biopharma alerts: Email Address Ad True Market InsidersExposed: 10 CENT Crypto to Explode April 20th?Former Wall Street Insider and Professional Money Manager Reveals 4 Cryptos BETTER Than BitcoinClick For My #1 FREE Crypto for 2024 About Liberty Biopharma Stock (CVE:LTY)Liberty Biopharma Inc., a clinical stage biopharmaceutical company, engages in the research, development, and commercialization of an automated bioprocessing and cell isolation technology. Its technology is used in the isolation of regenerative cells from human adipose tissues for use in research, cosmetic and aesthetic medicine, burn management, wound management and non-healing wounds, cardiovascular and heart diseases, peripheral arterial disease, critical limb ischemia or diabetic leg, and hepatic disease and kidney disease. The company was formerly known as Avagenesis Corp. and changed its name to Liberty Biopharma Inc. in January 2017. Liberty Biopharma Inc. is based in Richmond, Canada.Read More LTY Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart LTY Stock News HeadlinesApril 24, 2024 | americanbankingnews.comLiberty Biopharma (CVE:LTY) Stock Price Passes Above Fifty Day Moving Average of $2.00April 16, 2024 | americanbankingnews.comLiberty Biopharma (CVE:LTY) Stock Price Passes Above 50-Day Moving Average of $2.00April 24, 2024 | True Market Insiders (Ad)Exposed: 10 CENT Crypto to Explode April 20th?Former Wall Street Insider and Professional Money Manager Reveals 4 Cryptos BETTER Than BitcoinJanuary 3, 2024 | msn.comWhy Liberty Latin America Ltd. (LILA) Has an Undervalued Rating?January 3, 2024 | markets.businessinsider.comABVC BioPharma and its Subsidiary Receive $460M From AiBtl BioPharma as the First Milestone Payment of Global Licensing FeesDecember 29, 2023 | bizjournals.comLiberty Hospital is still recovering systems days after cyber attackDecember 27, 2023 | morningstar.comRedhill Biopharma Ltd ADRDecember 23, 2023 | news.yahoo.comMoms for Liberty faces growing challenges amid Florida sex scandalApril 24, 2024 | True Market Insiders (Ad)Exposed: 10 CENT Crypto to Explode April 20th?Former Wall Street Insider and Professional Money Manager Reveals 4 Cryptos BETTER Than BitcoinDecember 22, 2023 | msn.comOne Liberty (OLP) Completes Asset Sale Worth $63M in 2023December 21, 2023 | msn.comDelayed Liberty Hospital surgery could cost patient thousands if IT issues continueDecember 18, 2023 | tmcnet.comLiberty Travel Partners with Affirm to Bring Travelers a More Flexible Way to Book TripsDecember 16, 2023 | sfgate.comLiberty 99, St. Andrews 26December 16, 2023 | msn.comHere's Why Liberty Park Capital's Short Position in Powell Industries (POWL) DetractedDecember 13, 2023 | usatoday.comLiberty Home Guard reviewDecember 12, 2023 | reuters.comLiberty Media to merge unit with SiriusXM to create new public companyDecember 7, 2023 | news.yahoo.comMoms for Liberty's vision for America's future is narrow and dark. Why not help kids?November 29, 2023 | seekingalpha.comLDDFF Liberty Defense Holdings, Ltd.November 27, 2023 | marketwatch.comRedHill Biopharma Shares Double on FDA's 5-Year Market Exclusivity GrantNovember 22, 2023 | morningstar.comImmunotech Biopharm Ltd Ordinary Shares 06978November 5, 2023 | investing.comImmunotech Biopharm Ltd (6978)November 1, 2023 | msn.comLiberty Broadband: How To Buy Charter At A 50%+ DiscountOctober 25, 2023 | bizjournals.comRaleigh area layoffs blow past 2,000 in 2023. Here are the companies cutting jobsOctober 25, 2023 | nj.comKeep Liberty State Park free and open | Jersey Journal editorialOctober 24, 2023 | tmcnet.comLIBERTY LATIN AMERICA HOSTS FIRST AI FOCUSED EVENT - CX SPARKOctober 23, 2023 | msn.comLiberty Mutual Re names Alex Koh as senior underwriter in SingaporeOctober 19, 2023 | markets.businessinsider.comLiberty Advisor Group Appoints Greg Petraetis as Senior AdvisorSee More Headlines Receive LTY Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Liberty Biopharma and its competitors with MarketBeat's FREE daily newsletter. Email Address Industry, Sector and Symbol Stock ExchangeCVE SectorMedical Industry Biotechnology Sub-IndustryN/A Current SymbolCVE:LTY Previous SymbolCVE:VVA CUSIPN/A CIKN/A Webwww.libertybiopharma.com Phone+1-604-3777575FaxN/AEmployeesN/AYear FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity Ratio8.19 Current Ratio0.12 Quick Ratio0.12 Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowC$0.00 per share Price / Cash Flow2,000.00 Book ValueC$0.79 per share Price / Book2.53Miscellaneous Outstanding Shares10,770,000Free FloatN/AMarket CapC$21.54 million OptionableNot Optionable BetaN/A Elon Musk's Next MoveWondering when you'll finally be able to invest in SpaceX, StarLink, or The Boring Company? Click the link below to learn when Elon Musk will let these companies finally IPO.Get This Free Report Key ExecutivesMr. Norman Tsui (Age 45)Pres, CEO & Director Mr. Shui Yan Tam (Age 44)Chief Financial Officer Dr. Michael T. McNamaraMedical Advisor & DirectorDr. Richard Huang Ph.D. (Age 42)Chief Technology Officer Dr. Richard Cook M.D.Msc., FRCSC, Chief Medical OfficerKey CompetitorsCeaproCVE:CZOAcasti PharmaCVE:ACSTAptose BiosciencesTSE:APSKane BiotechCVE:KNEReunion NeuroscienceTSE:REUNView All Competitors LTY Stock Analysis - Frequently Asked Questions How have LTY shares performed in 2024? Liberty Biopharma's stock was trading at C$2.00 at the beginning of 2024. Since then, LTY shares have increased by 0.0% and is now trading at C$2.00. View the best growth stocks for 2024 here. What other stocks do shareholders of Liberty Biopharma own? Based on aggregate information from My MarketBeat watchlists, some companies that other Liberty Biopharma investors own include Cross Timbers Royalty Trust (CRT), InfraCap MLP ETF (AMZA), Alliance Resource Partners (ARLP), Brigham Minerals (MNRL), Arbor Realty Trust (ABR), Advanced Emissions Solutions (ADES), Archer-Daniels-Midland (ADM), AGNC Investment (AGNC) and AMC Entertainment (AMC). How do I buy shares of Liberty Biopharma? Shares of LTY stock and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor, Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers.Compare Top Brokerages Here. This page (CVE:LTY) was last updated on 4/24/2024 by MarketBeat.com Staff From Our Partnerstop AI stock (it’s not MSFT, GOOGL, AMZN or AAPL)Traders AgencyDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsBitcoin Rockets To Record High But Buy THIS InsteadParadigm PressExposed: 10 CENT Crypto to Explode April 20th?True Market InsidersThe #1 Crypto for 2024InvestorPlaceDon’t Miss Out on the AI Gold Rush That’s Just Getting StartedBanyan Hill PublishingEmergency: Biden's $20 Trillion Mistake Could Cost YOU!GoldenCrest MetalsA.I. is a Tidal Wave - Here’s What to BuyChaikin Analytics Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Liberty Biopharma Inc Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
